arrow
D

Dimitrios Richter

chariteuniversitatsmedizin berlin
H指数:41
被引数:6.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

From consensus to action: Implementing cardiovascular prevention guidelines in primary healthcare

从共识到行动:在初级保健中实施心血管预防指南

2025-11-010
OA
2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias

2025年《2019 ESC/EAS血脂异常管理指南》聚焦更新版

2025-08-290
PRE
2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias: Developed by the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)

Mach, F.; Koskinas, K.C.; Roeters van Lennep, J.E.; Tokgözoğlu, L.; Badimon, L.; Baigent, C.; Benn, M.; Binder, C.J.; Catapano, A.L.; De Backer, G.G.; 等. 2019年ESC/EAS血脂异常管理指南2025年重点更新版:由欧洲心脏病学会(ESC)和欧洲动脉粥样硬化学会(EAS)血脂异常管理工作组制定。Eur. Heart J. 2025, ehaf190. [Google Scholar] [CrossRef] [PubMed]

2025-08-0171
PRE
Cardiovascular risk factors management in older adults: a clinical consensus statement from the European Association of Preventive Cardiology of the ESC and the ESC Council for Cardiology Practice

心血管危险因素管理在老年成人中的应用:欧洲预防心脏病学协会(ESC)和欧洲心脏病学会(ESC)心脏病学实践委员会的临床共识声明

2025-08-011
OAAI
Digital health in older adults for the prevention and management of cardiovascular diseases and frailty. A clinical consensus statement from the ESC Council for Cardiology Practice/Taskforce on Geriatric Cardiology, the ESC Digital Health Committee and the ESC Working Group on e-Cardiology
2022-07-1225
OA
2018 ESC/EACTS Guidelines on myocardial revascularization
2018-08-27202
OAAI
2018 ESC/EACTS Guidelines on myocardial revascularization
2018-08-251.6K
OAAI
2017 ESC/EACTS Guidelines for the management of valvular heart disease The Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)

2017 ESC/EACTS瓣膜性心脏病管理指南欧洲心脏病学会 (ESC) 和欧洲心胸外科协会 (EACTS) 瓣膜性心脏病管理工作组

2017-08-261.2K
OAAI
The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement
2017-06-01241
PREAI
2016 European Guidelines on cardiovascular disease prevention in clinical practice
2016-09-0954
OA
2016 European Guidelines on cardiovascular disease prevention in clinical practice The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)
2016-09-013.3K
OAAI
2016 European Guidelines on cardiovascular disease prevention in clinical practice
2016-05-232.3K
OAAI
Short-term outcome and attainment of secondary prevention goals in patients with acute coronary syndrome-Results from the countrywide TARGET study
2013-09-0132
PREAI